Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

450

HTML

4124

Figures (1-5)

267

Tables (1-5)

208

Sum=5049

May 28, 2012 (publication date) through Sep 6, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. May 28, 2012; 18(20): 2481-2492
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2481

Table 4 Effects of trinitrobenzene sulfonic acid concentration on body weight and mortality rate

^aP < 0.05,

^bP < 0.01 vs saline-treated group;

^dP < 0.01 vs TNBS (20 mg/0.8 mL)-treated group. TNBS: Trinitrobenzene sulfonic acid.

Citation: Qin HY, Xiao HT, Wu JC, Berman BM, Sung JJ, Bian ZX. Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats. World J Gastroenterol 2012; 18(20): 2481-2492
URL: https://www.wjgnet.com/1007-9327/full/v18/i20/2481.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i20.2481